An evaluation using di-electrophoresis array (DEPArray) technology has been used for single cell sorting in CSF CTCs in a patient with LM secondary to HER2 positive gastric cancer; it found that 21.8% of CTCs were actually HER2 negative [41]. Here, ERBB2 is linked to gastric cancer.